Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

No reported Effect of Forex Changes figures are available to summarize.

Effect of Forex Changes history

Currency unavailable · from the cash flow

No Effect of Forex Changes data reported for this period type.

Effect of Forex Changes vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Effect of Forex Changes for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$1.67M USD-118.2%+34.5%23.5%
CYTKCytokinetics, IncorporatedLTM Jun 2026$841K USD+7.0%—1.2%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$0 USD———
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-55.6%+34.5%0.6%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.